Stocks like Bajaj Finance Ltd., Gensol Engineering, Biocon Ltd., Central Bank of India, Adani Green Energy Ltd. and NHPC along with others are set to see action going into trade on Thursday.

  • Bajaj Finance: The company is considering a stock split and bonus issue on April 29, 2025.

  • Gensol Engineering: The company clarifies that it has not received any communication or notice from ED in connection with the Mahadev Book app case. The promoters have no association with the Mahadev Book app case or alleged financial transactions.

  • Biocon: The company will be in focus after the board approved the raising of funds up to Rs 4,500 crore via NCDs or other means.

  • Central Bank of India:  The board of the bank is set to consider raising funds via QIP, preferential issue, or other means.

  • Adani Green: The company’s step-down arm signed an agreement with Uttar Pradesh Power Corp for energy storage capacity supply from Pumped Hydro Storage Projects.

  • NHPC: The company to develop a 1,200 MW solar park in Uttar Pradesh for Rs 797 crore and an Investment of Rs 239 crore in arm Bundelkhand Saur Urja for the development of the 1,200 MW solar park.

  • Panacea Biotec: The company received a $5.2 million order from Unicef for polio vaccine.

  • 360 One WAM: The company reappointed Karan Bhagat as MD for five years from July 27, 2025, and approved fund raising up to Rs 250 crore via NCDs.

  • Niva Bupa Health: The company received Irdai approval for the reappointment of Krishnan Ramachandran as MD and CEO for five years from May 1.

  • Deepak Fertilizers And Petrochemicals: The company incorporated wholly owned subsidiary Deepak Globalchem in Singapore.

  • Tips Music: The board has re-appointed Kumar Taurani as the company’s Chairman and Managing Director, effective June 1, entrusting him with leadership responsibilities.

  • Max Estates: The company has received NCLT approval to acquire 100% stake in the Boulevard Project, making it a wholly-owned arm. The company will take over the Delhi One project in Noida under the Insolvency & Bankruptcy Code. The Delhi One project is estimated to generate Rs 2,000 crore in sales and Rs 120 crore in annual rentals.

Q4 Earnings Post Market Hours

Tata Consumer Products Q4 Highlights (Consolidated, YoY)

  • Revenue up 17.3% to Rs 4,608 crore versus Rs 3,927 crore (Bloomberg estimate: Rs 4,555.7 crore)

  • Net Profit up 59% to Rs 345 crore versus Rs 217 crore (Bloomberg estimate: Rs 225 crore)

  • Ebitda down 1% to Rs 621 crore versus Rs 630 crore (Bloomberg estimate: Rs 612 crore)

  • Margin at 13.5% versus 16% (Bloomberg estimate: 13.4%)

  • Exceptional items include gain of Rs 120 crore and Rs 72 crore of asset written down.

  • The board has recommended a dividend of Rs 8.25 per equity share for FY25.

  • India branded business revenue grew by 18.4% to Rs 2,936.72 crore.

  • International branded business revenue grew by 13.4% to Rs 1,193.68 crore.

  • 25% growth in non-branded business at Rs 500.55 crore.

 LTIMindtree Q4 Highlights (Consolidated, QoQ)

  • Revenue up 1.1% to Rs 9,772 crore versus Rs 9,661 crore (Bloomberg estimate: Rs 9,868 crore)

  • Net Profit up 4% to Rs 1,128.5 crore versus Rs 1,085.4 crore (Bloomberg estimate: Rs 1,165 crore)

  • Ebit up 1% to Rs 1,342.3 crore versus Rs 1,329 crore (Bloomberg estimate: Rs 1,705.2 crore)

  • Margin at 13.7% versus 13.8% (Bloomberg estimate: 17.3%)

  • LTIMindtree board has recommended a final dividend of Rs 45 per equity share.

 Tamilnad Mercantile Bank Q4 Highlights (Standalone, YoY)

  • Net Profit up 15.3% at Rs 292 crore versus Rs 253 crore

  • Net interest income flat at Rs 568 crore

  • Gross NPA at 1.25% versus 1.32% (QoQ)

  • Net NPA at 0.36% versus 0.41% (QoQ)

 360 One WAM Q4 Results (Consolidated, YoY)

  • Revenue up 3.7% to Rs 820.77 crore versus Rs 791.17 crore.

  • Net Profit up 3% to Rs 249.6 crore versus Rs 242.61 crore.

Thyrocare Tech Q4 FY25 (Cons, YoY)

  • Revenue up 21.3% at Rs 187 crore versus Rs 154 crore

  • Ebitda up 70.7% at Rs 57.7 crore versus Rs 33.8 crore

  • Margin at 30.8% vs 21.9%

  • Net profit up 22% at Rs 21.7 crore versus Rs 17.8 crore.

  • Pathology and Radiology segments grew by 23% YoY and 7% YoY respectively

  • Revenue from franchise surged by 22% YoY, and partnership revenue saw 24% YoY growth

  • Board recommends final dividend of `21/share

 Bajaj Housing Finance Q4 Results (YoY)

  • Net Profit up 54% to Rs 587 crore versus Rs 381 crore (Bloomberg estimate: Rs 557 crore)

  • Net interest income up 31% to Rs 823 crore versus Rs 629 crore.

  • Assets under Management up 26% to Rs 1.15 lakh crore

Can Fin Homes Q4 Highlights (YoY)

  • Total Income up 7.8% to Rs 1,000 crore versus Rs 928 crore.

  • Net profit up 11.9% to Rs 234 crore versus Rs 209 crore.

Supreme Petrochem Q4 Highlights (Consolidated, YoY)

  • Revenue down 1.5% to Rs 1,539 crore versus Rs 1,563 crore.

  • Ebitda down 17.4% to Rs 145 crore versus Rs 175 crore.

  • Margin to 9.4% versus 11.2%.

  • Net profit down 18.7% to Rs 107 crore versus Rs 132 crore.

Syngene International Q4 Highlights (Consolidated, YoY)

  • Revenue up 11% to Rs 1,018 crore versus Rs 917 crore (Bloomberg estimate: Rs 1,048.8 crore).

  • Ebitda up 8.4% to Rs 344 crore versus Rs 317 crore (Estimate: Rs 364.8 crore).

  • Margin narrows to 33.8% versus 34.6% (Estimate: 34.8 %).

  • Net profit down 2.8% to Rs 183 crore versus Rs 189 crore (Estimate: Rs 192.9 crore).

Supreme Petrochem Q4 Highlights (Consolidated, YoY)

  • Revenue down 1.5% to Rs 1,539 crore versus Rs 1,563 crore.

  • Ebitda down 17.4% to Rs 145 crore versus Rs 175 crore.

  • Margin to 9.4% versus 11.2%.

  • Net profit down 18.7% to Rs 107 crore versus Rs 132 crore.

Dalmia Bharat Q4FY25 (Consolidated, YoY)

  • Revenue down 5% to Rs 4,091 crore versus Rs 4,307 crore (Estimate: Rs 4232 crore).

  • Ebitda up 21% to Rs 793 crore versus Rs 654 crore (Estimate: Rs 788 crore).

  • Margin at 19.4% versus 15.2% (Estimate: 18.6%)

  • Net Profit up 38% to Rs 435 crore versus Rs 315 crore (Estimate: Rs 297 crore)

Astec Lifesciences Q4 Earnings- (Cons, YoY)

  • Revenue down 22.3% at Rs 120 crore versus Rs 154 crore

  • EBITDA down 56.6% at Rs 5.5 crore versus Rs 12.7 crore

  • Margin at 4.6% vs 8.3%

  • Net loss of Rs 16 crore vs loss of Rs 1 crore

    Rallis India Q4 FY25 (Cons, YoY)

  • Revenue down 1.38% at Rs 430 crore versus Rs 436 crore.

  • Ebitda loss at Rs 20 crore versus profit of Rs 6 crore.

  • Net loss at Rs 32 crore versus loss of Rs 21 crore.

Q4 Earnings In Focus

Hindustan Unilever, Nestle India, SBI Life, Axis Bank, Tech Mahindra, L&T and Persistent Systems among others are the big names set to announce their quarterly results.

. Read more on Markets by NDTV Profit.Stock like Central Bank of India, Adani Green and NHPC are set to see action going into trade on Thursday.  Read MoreMarkets, Notifications 

​NDTV Profit